Stroke Trial, Recruiting NCT06839482 Sponsor: IRCCS San Raffaele Roma Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06839482
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 90 years, of any sex
  • People who have weakness in one arm caused by a recent stroke (either a blocked blood vessel or a bleed in the brain)
  • People whose arm weakness is mild to moderate — specifically, some movement is still possible in the thumb, fingers, and wrist even without gravity helping, as measured by a standard muscle strength scale (MRC score of 2 or higher)
  • People who are within 90 days of their stroke
  • People who are able to understand the study information and sign a consent form
  • People who are physically able to carry out the study activities

Who may not be able to join:

  • People who have other neurological conditions in addition to their stroke
  • People who have joint, bone, or muscle conditions that affect movement in their arm
  • People with severe psychiatric (mental health) disorders
  • People with severe difficulties in thinking or understanding language that would prevent them from following exercise instructions (as measured by a standard cognitive test, with a score of 17 or below)
  • People who have had botulinum toxin (such as Botox) injected into the affected arm in the past 60 days, or for whom such treatment is planned during the study period
  • People who have open wounds, infections, or unprotected skin sores on the arm
  • People who have severe muscle stiffness (spasticity) in the arm, specifically in the bicep, wrist, or finger muscles (as measured by a standard scale, with a score above 3)
  • People who are unlikely to follow the exercise program consistently
  • People who have not signed the study consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sanaz Pournajaf, DPT, PhD, IRCCS San Raffaele Roma

Phone: +39 0652252405

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
IRCCS San Raffaele Roma
Registry
ClinicalTrials.gov
Start date
6 February 2025
Est. completion
28 February 2026

Where this trial is recruiting

🇨🇿 Czechia 🇮🇹 Italy 🇷🇺 Russia 🇪🇸 Spain 🇹🇭 Thailand 🇺🇸 United States

Primary endpoints

Fugle Meyer Assessment for Upper Limb - Motor Part (score range: 0-66)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov